ASTEC

ASTEC LIFESCIENCES

Small Cap BSE: 533138 NSE: ASTEC
₹2045.7
-29.1 (-1.4%)
  • Advice
  • Hold
As on 01 December, 2022 | 04:49

Astec Lifesciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in ASTEC LIFESCIENCES

Start SIP

Astec Lifesciences Share Price

Astec Lifesciences Share Returns

  • Over 1 Month -5.87%
  • Over 3 Month 6.02%
  • Over 6 Month 10.88%
  • Over 1 Year 54.95%

Astec Lifesciences Key Statistics

P/E Ratio 41.1
PEG Ratio 0.5
Market Cap Cr 4,011
Price to Book Ratio 10.1
EPS 45.8
Dividend 0.1
Relative Strength Index 43.03
Money Flow Index 41.54
MACD Signal 21.32
Average True Range 79

Astec Lifesciences Investment Rating

  • Master Rating:
  • Astec Lifesciences has an operating revenue of Rs. 829.35 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 18% is great, ROE of 22% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 11% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -6% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 110 indicates it belongs to a poor industry group of Chemicals-Agricultural and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Astec Lifesciences Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 200184272173103129172
Operating Expenses Qtr Cr 16615920713081104134
Operating Profit Qtr Cr 33256543212538
Depreciation Qtr Cr 89119877
Interest Qtr Cr 5433221
Tax Qtr Cr 64158348
Net Profit Qtr Cr 1811432591324

Astec Lifesciences Technicals

EMA & SMA

Current Price
2045.7
-29.1 (-1.4%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 2123.36
  • 50 Day
  • 2075.77
  • 100 Day
  • 1998.07
  • 200 Day
  • 1860.38
  • 20 Day
  • 2139
  • 50 Day
  • 2057.65
  • 100 Day
  • 1992.89
  • 200 Day
  • 1860.62

Astec Lifesciences Resistance and Support

PIVOT
₹2089.99
Resistance
First Resistance 2114.82
Second Resistance 2154.84
Third Resistance 2179.67
RSI 43.03
MFI 41.54
MACD Single Line 21.32
MACD 2.23
Support
First Resistance 2049.97
Second Resistance 2025.14
Third Resistance 1985.12

Astec Lifesciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 108,013 8,871,108 82.13
Week 34,801 2,508,470 72.08
1 Month 27,424 1,517,096 55.32
6 Month 39,746 2,127,580 53.53

Astec Lifesciences Result Highlights

Astec Lifesciences Synopsis

NSE-Chemicals-Agricultural

Astec Lifesciences L is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 676.57 Cr. and Equity Capital is Rs. 19.60 Cr. for the Year ended 31/03/2022. Astec Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1994PLC076236 and registration number is 076236.
Market Cap 4,011
Sales 829
Shares in Float 0.65
No of funds 35
Yield 0.07
Book Value 10.12
U/D Vol ratio 1.5
LTDebt / Equity 13
Alpha 0.17
Beta 0.91

Astec Lifesciences

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 66.77%65.29%65.29%
Mutual Funds 8.71%7.98%8.5%
Insurance Companies 2.26%2.66%
Foreign Portfolio Investors 1.53%0.48%0.32%
Financial Institutions/ Banks
Individual Investors 18.02%18.26%17.46%
Others 4.97%5.73%5.77%

Astec Lifesciences Management

Name Designation
Mr. Nadir B Godrej Chairman
Mr. Ashok V Hiremath Non Executive Director
Mr. Balram Singh Yadav Non Executive Director
Mr. Anurag Roy WholeTime Director & CEO
Dr. Brahma Nand Vyas Ind. Non-Executive Director
Mr. Vijay Kashinath Khot Ind. Non-Executive Director
Mr. R R Govindan Ind. Non-Executive Director
Mr. Nandkumar Dhekne Ind. Non-Executive Director
Ms. Anjali Gupte Independent Director
Mr. Burjis Nadir Godrej Non Exe.Non Ind.Director

Astec Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Astec Lifesciences Corporate Action

Date Purpose Remarks
2022-10-28 Quarterly Results
2022-07-25 Quarterly Results
2022-05-02 Audited Results & Final Dividend
2022-01-25 Quarterly Results
2021-10-27 Quarterly Results

Astec Lifesciences MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 22844
Nippon India Multi Cap Fund - Growth 14025
ICICI Prudential Multicap Fund Growth 7027
ICICI Prudential Smallcap Fund Growth 4388
UTI Small Cap Fund Regular Growth 2386

Astec Lifesciences FAQs

What is Share Price of Astec Lifesciences ?

Astec Lifesciences share price is ₹2045 As on 01 December, 2022 | 04:35

What is the Market Cap of Astec Lifesciences ?

The Market Cap of Astec Lifesciences is ₹4010.5 Cr As on 01 December, 2022 | 04:35

What is the P/E ratio of Astec Lifesciences ?

The P/E ratio of Astec Lifesciences is 41.1 As on 01 December, 2022 | 04:35

What is the PB ratio of Astec Lifesciences ?

The PB ratio of Astec Lifesciences is 10.1 As on 01 December, 2022 | 04:35

Q2FY23